|
NCT00189800
|
|
A Study of Solifenacin Succinate Compared to Tolterodine in Patients With Overactive Bladder
|
Phase 3
|
Completed
|
|
NCT02317601
|
2014-12-01 |
Preoperative Single Glucocorticoid Hip Fracture Hip Fracture Surgery
|
Phase 4
|
Not Yet Recruiting
|
|
NCT02112916
|
2014-09-01 |
Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma
|
Phase 3
|
Recruiting
|
|
NCT02176655
|
2014-07-01 |
Pilot Study of VVD-101 for the Treatment of Delayed Alcohol-Induced Headaches
|
Phase 2
|
Recruiting
|
|
NCT02169713
|
2014-05-01 |
Study to Evaluate the Effect of Solifenacin and Mirabegron on the Tamsulosin Hydrochloride (HCl) Concentrations in Blood in Healthy Male Subjects
|
Phase 1
|
Completed
|
|
NCT01970501
|
2014-04-01 |
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
|
Phase 2
|
Recruiting
|
|
NCT02045862
|
2014-03-01 |
A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder
|
Phase 3
|
Enrolling By Invitation
|
|
NCT01974934
|
2013-12-01 |
Efficacy and Safety Study of Desvenlafaxine in the Treatment of Vascular Depression
|
Phase 4
|
Recruiting
|
|
NCT02012075
|
2013-12-01 |
A Phase Ⅲ Study of Extended-Release Carvedilol Sulfate for the Treatment of Heart Failure
|
Phase 3
|
Recruiting
|
|
NCT01977781
|
2013-12-01 |
Safety and Efficacy of Topical Tacrolimus 0.05% in the Treatment of Ocular Graft-Versus-Host Disease
|
Phase 1
|
Recruiting
|
|
NCT01972841
|
2013-11-01 |
This is a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder
|
Phase 3
|
Recruiting
|
|
NCT01981954
|
2013-10-01 |
A Clinical Study to Investigate How Solifenacin Fluid is Taken up, How Long it Stays in the Body and How Effective and Safe it is in Treating Children Aged From 6 Months to Less Than 5 Years With Symptoms of Neurogenic Detrusor Overactivity (NDO)
|
Phase 3
|
Suspended
|
|
NCT01970059
|
2013-10-01 |
A Phase Ⅲ Study of Extended-Release Carvedilol Sulfate for the Treatment of Hypertension
|
Phase 3
|
Recruiting
|
|
NCT01908829
|
2013-07-01 |
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
|
Phase 3
|
Completed
|
|
NCT01884857
|
2013-04-01 |
Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 50 mg
|
Phase 1
|
Completed
|
|
NCT02094703
|
2013-04-01 |
The Efficacy of Solifenacin Succinate as Adjuvant Therapy for Urinary Tract Infection in Females
|
Phase 4
|
Recruiting
|
|
NCT01884909
|
2013-04-01 |
Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fed Conditions
|
Phase 1
|
Completed
|
|
NCT01807000
|
2013-03-01 |
Absorption, Metabolism and Excretion (AME) of Single Dose Radiolabeled Prucalopride Succinate in Volunteers
|
Phase 1
|
Completed
|
|
NCT01777217
|
2013-02-01 |
VESIcare For Improving OAB Symptoms in Patients Undergoing IGRT of the Prostate
|
Phase 4
|
Terminated
|
|
NCT01884896
|
2013-02-01 |
Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fasting Conditions
|
Phase 1
|
Completed
|
|
NCT01747577
|
2012-12-01 |
Post Marketing Study to Evaluate the Efficacy and Safety of Solifenacin in Patients With OAB (Overactive Bladder) After TURP (Trans-urethral Resection of Prostate) or PVP (Photoselective Vaporization of Prostate)
|
Phase 4
|
Completed
|
|
NCT01655069
|
2012-10-01 |
A Study to Investigate How Safe and Effective Solifenacin Solution is in Treating Children/Adolescents With Symptoms of Overactive Bladder (OAB) Who Completed Study 905-CL-076
|
Phase 3
|
Completed
|
|
NCT02010944
|
2012-09-01 |
A Study to Compare How Much Solifenacin Succinate and Mirabegron Reach the Blood When Administered Together as Fixed-dose Combination Tablets and With Single Individual Tablets of the Same Medications at Three Dose Levels
|
Phase 1
|
Completed
|
|
NCT01565707
|
2012-06-01 |
A Study to Investigate How Effective and Safe Solifenacin Succinate Suspension is in Treating Children/Adolescents Aged 5 to Less Than 18 Years With Symptoms of Overactive Bladder (OAB) Compared to a Non-active Drug
|
Phase 3
|
Completed
|
|
NCT01638000
|
2012-06-01 |
A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Are Previously Treated With Another Medicine But Were Not Satisfied With That Treatment
|
Phase 3
|
Completed
|
|
NCT01605370
|
2012-06-01 |
Can Nebivolol Reverse Inappropriate Left Ventricular Mass in Hypertensive Patients?
|
Phase 4
|
Terminated
|
|
NCT01565694
|
2012-05-01 |
A Study to Assess the Long Term Effect, Safety and Metabolism of a Solifenacin Liquid Suspension in Patients 5 to 18 Years of Age With Neurogenic Detrusor Overactivity
|
Phase 3
|
Recruiting
|
|
NCT01539707
|
2012-03-01 |
Single Dose Study to Measure Blood Levels and Safety of a Drug for Children With Overactive Bladder
|
Phase 1
|
Completed
|
|
NCT01353963
|
2012-03-01 |
Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino Patients
|
Phase 4
|
Completed
|
|
NCT01406756
|
2012-02-01 |
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
|
Phase 3
|
Recruiting
|
|
NCT01676285
|
2012-01-01 |
Metoprolol Succinate in Cardiac Remodeling Related to Cirrhosis
|
Phase 3
|
Completed
|
|
NCT01372150
|
2011-11-01 |
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
|
Phase 3
|
Recruiting
|
|
NCT01833663
|
2011-10-01 |
Effectiveness and Safety Study of Solifenacin Succinate and Solifenacin Succinate + Estrogen to Treat OAB in Postmenopausal Women
|
Phase 4
|
Completed
|
|
NCT01432457
|
2011-10-01 |
Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)
|
Phase 4
|
Completed
|
|
NCT01371994
|
2011-08-01 |
A Study to Assess Efficacy and Safety With Solifenacin Succinate to Improve Urinary Continence After Robotic Assisted Radical Prostatectomy
|
Phase 4
|
Completed
|
|
NCT01371734
|
2011-08-01 |
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
|
Phase 3
|
Recruiting
|
|
NCT01499134
|
2011-08-01 |
Comparison of 2 Beta Blocker Drugs on Peripheral Arterial Disease in Patients With High Blood Pressure
|
Phase 3
|
Completed
|
|
NCT01569516
|
2011-06-01 |
Study of Octohydroaminoacridine Succinate Tablets in Patients With Alzheimer's Disease
|
Phase 2
|
Recruiting
|
|
NCT01406158
|
2011-05-01 |
A Study in Healthy Volunteers Comparing Two Different Liquid Formulations of Solifenacin With Each Other and With the Tablet Formulation
|
Phase 1
|
Completed
|
|
NCT01340027
|
2011-03-01 |
A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Alone and in Combination for the Treatment of Overactive Bladder
|
Phase 2
|
Completed
|
|
NCT01694797
|
2011-01-01 |
Bioequivalence Study for Metoprolol Succinate ER Tablets 50 mg Under Fasting Condition
|
Phase 1
|
Completed
|
|
NCT01673997
|
2010-12-01 |
Bioequivalence Study of Metoprolol Succinate ER Tablets, 200 mg Under Fasting Conditions
|
Phase 1
|
Completed
|
|
NCT01486706
|
2010-10-01 |
Efficacy and Safety of Gabapentin in Treating Overactive Bladder
|
Phase 4
|
Active, Not Recruiting
|
|
NCT01213173
|
2010-10-01 |
Evaluation of Succinate Metoprolol on Heart Rate in the Stable Angina Patients
|
Phase 4
|
Completed
|
|
NCT01381120
|
2010-10-01 |
Therapeutic Merit of Solifenacin in the Mitigation of Ureteral Stent-induced Pain and Lower Urinary Tract Symptoms
|
Phase 4
|
Completed
|
|
NCT01190514
|
2010-09-01 |
Phase 1 Study To Test the Bioequivalence Between Two 25 mg Tablets vs. One 50 mg Tablet Under Fast/Fed Condition and Evaluate Food Effect of Desvenlafaxine Succinate Sustained Release (DVS SR)
|
Phase 1
|
Completed
|
|
NCT01501929
|
2010-08-01 |
Effects of Nebivolol on Skeletal Muscle During Exercise in Hypertensive Patients
|
Phase 4
|
Recruiting
|
|
NCT01189500
|
2010-08-01 |
Open-Label Drug Interaction Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) 100mg On The Pharmacokinetics Of Tamoxifen When Coadministered To Healthy Post-Menopausal Female Subjects
|
Phase 4
|
Completed
|
|
NCT01188668
|
2010-08-01 |
Open Label Drug Interaction Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) 100mg On The Pharmacokinetics Of Aripiprazole When Coadministered To Healthy Subjects
|
Phase 4
|
Completed
|
|
NCT01121484
|
2010-06-01 |
Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Peri- And Postmenopausal Women With Major Depressive Disorder (DVS 3364)
|
Phase 4
|
Completed
|
|
NCT00952653
|
2010-06-01 |
Study Evaluating the Effect of Desvenlafaxine on the Pharmacokinetics of Midazolam
|
Phase 4
|
Completed
|
|
NCT01101152
|
2010-04-01 |
Effectiveness of the Dual Serotonin Norepinephrine Reuptake Inhibitor Desvenlafaxine Succinate in Healthy Volunteers
|
Phase 1
|
Recruiting
|
|
NCT01021332
|
2010-04-01 |
Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract Symptoms
|
Phase 3
|
Completed
|
|
NCT01056289
|
2010-03-01 |
Study Comparing Discontinuation Symptoms Of DVS SR In Subjects With Major Depressive Disorder (MDD)
|
Phase 4
|
Completed
|
|
NCT01018264
|
2010-01-01 |
Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease
|
Phase 4
|
Active, Not Recruiting
|
|
NCT01018511
|
2010-01-01 |
Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms
|
Phase 3
|
Completed
|
|
NCT01381796
|
2009-12-01 |
Compare PK and Bioavailability of 2 NP101 Patches With Oral Imitrex in Healthy Adults
|
Phase 1
|
Completed
|
|
NCT01041287
|
2009-12-01 |
Effect of Nebivolol on Oxidative Stress and Endothelial Progenitor Cells
|
Phase 4
|
Completed
|
|
NCT01015040
|
2009-09-01 |
Relative Bioavailability Study of Solifenacin Succinate Liquid Suspension (Fed and Fasting) Versus VESIcare Tablet (Fasting) in Healthy Volunteers
|
Phase 1
|
Completed
|
|
NCT00893737
|
2009-06-01 |
"""Completeness of Response"" Following Treatment With Treximet™ for Migraine"
|
Phase 4
|
Completed
|
|
NCT00887224
|
2009-06-01 |
Relapse Prevention Study Of Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder
|
Phase 3
|
Completed
|
|
NCT00888862
|
2009-06-01 |
Desvenlafaxine Succinate (DVS) for Major Depressive Disorder (MDD) in Midlife Men and Women
|
Phase 3
|
Recruiting
|
|
NCT00920686
|
2009-06-01 |
Study of NXN 188 for the Treatment of Migraine With Aura
|
Phase 2
|
Completed
|
|
NCT01502787
|
2009-04-01 |
Comparison of Nebivolol and Metoprolol With Exercise and Angiotensin II in Hypertensive Patients
|
Phase 4
|
Completed
|
|
NCT00863798
|
2009-04-01 |
Study Evaluating Desvenlafaxine Succinate Sustained Release In Adults With Major Depressive Disorder
|
Phase 3
|
Completed
|
|
NCT00831415
|
2009-03-01 |
Study Evaluating Long-Term Safety of Desvenlafaxine Succinate Sustained Release With Japanese Adult Subjects in Major Depressive Disorder (MDD)
|
Phase 3
|
Completed
|
|
NCT01297192
|
2009-03-01 |
A Clinical Study to Assess the Effect on Pharmacokinetics of Dosing Mirabegron (YM178) and Solifenacin Simultaneously
|
Phase 1
|
Completed
|
|
NCT00824291
|
2009-02-01 |
Study Evaluating Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder
|
Phase 3
|
Completed
|
|
NCT01005758
|
2009-01-01 |
Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
|
Phase 2
|
Not Yet Recruiting
|
|
NCT00818155
|
2009-01-01 |
Study Evaluating the Safety, Tolerability and Pharmacokinetics of Desvenlafaxine Succinate SR in Healthy Chinese Male and Females
|
Phase 1
|
Completed
|
|
NCT00798707
|
2008-12-01 |
Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) in the Treatment of Major Depressive Disorder
|
Phase 3
|
Completed
|
|
NCT00796315
|
2008-12-01 |
Study Evaluating the Pharmacokinetics of Doxylamine Succinate in Children
|
Phase 1
|
Completed
|
|
NCT00773552
|
2008-11-01 |
Solifenacin Succinate Versus Placebo in Inner City Women Ages 20-45 With Overactive Bladder
|
Phase 4
|
Not Yet Recruiting
|
|
NCT00723983
|
2008-11-01 |
Phase I, Open Label, Single-Dose, Four Way Crossover Study to Compare the PK of NP101 With Oral Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine Period
|
Phase 1
|
Completed
|
|
NCT00771394
|
2008-10-01 |
Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic Hyperplasia
|
Phase 4
|
Completed
|
|
NCT00720109
|
2008-07-01 |
Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
|
Phase 3
|
Active, Not Recruiting
|
|
NCT00727064
|
2008-06-01 |
Study Evaluating the Pharmacokinetics of Venlafaxine Extended-Release (ER) and Desvenlafaxine Succinate Sustained-Release (DVS SR) 50 mg in Healthy Subjects
|
Phase 1
|
Completed
|
|
NCT00683800
|
2008-06-01 |
Study Evaluating The Safety And Efficacy Of Desvenlafaxine Succinate For Vasomotor Symptoms In Menopausal Women
|
Phase 3
|
Completed
|
|
NCT00669110
|
2008-05-01 |
Study Evaluating Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR) In The Treatment Of Child and Adolescent Outpatients With Major Depressive Disorder
|
Phase 2
|
Completed
|
|
NCT00629642
|
2008-03-01 |
Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple Sclerosis
|
Phase 4
|
Completed
|
|
NCT00619619
|
2008-02-01 |
Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Child And Adolescent Outpatients With Major Depressive Disorder
|
Phase 2
|
Completed
|
|
NCT00614445
|
2008-01-01 |
The Efficacy Of Diclectin® For Nausea And Vomiting Of Pregnancy
|
Phase 3
|
Completed
|
|
NCT00584090
|
2007-11-01 |
Solifenacin Succinate (VESIcare) for the Treatment of Urinary Incontinence in Parkinson's Disease
|
Phase 4
|
Withdrawn
|
|
NCT00546650
|
2007-11-01 |
Phase I Study to Compare NP101(Sumatriptan Iontophoretic Transdermal Patch) With Three Formulations of Imitrex®
|
Phase 1
|
Completed
|
|
NCT00573508
|
2007-08-01 |
Study of VESIcare® In Overactive Bladder (OAB) Subjects to Evaluate Symptom Bother and Health Related Quality of Life
|
Phase 4
|
Completed
|
|
NCT00510419
|
2007-07-01 |
A Study to Assess an Auto-injector Being Used to Treat a Migraine Attack
|
Phase 3
|
Completed
|
|
NCT00507455
|
2007-06-01 |
Solifenacin Succinate With Tamsulosin HCl in Males With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction
|
Phase 2
|
Completed
|
|
NCT00627731
|
2007-06-01 |
Oral Glucocorticosteroid in the Treatment of Severe Asthma Exacerbation in Hospitalized Patients
|
Phase 4
|
Completed
|
|
NCT00476190
|
2007-04-01 |
ALL Adult Consortium Trial: Adult ALL Trial
|
Phase 2
|
Active, Not Recruiting
|
|
NCT00510406
|
2007-01-01 |
A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPH
|
Phase 2
|
Completed
|
|
NCT00433043
|
2007-01-01 |
BOAT: Beta Blocker Uptitration With OptiVol After Cardiac Resynchronization Therapy (CRT)
|
Phase 4
|
Terminated
|
|
NCT00401245
|
2006-12-01 |
The Effect Of Dose Titration And Dose Tapering On The Tolerability Of DVS SR In Women With Vasomotor Symptoms
|
Phase 3
|
Completed
|
|
NCT00406640
|
2006-12-01 |
Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) vs. Escitalopram in Postmenopausal Women
|
Phase 3
|
Completed
|
|
NCT00397176
|
2006-11-01 |
Study Evaluating Safety, Tolerability, and PK of DVS SR in Healthy Japanese Women
|
Phase 1
|
Completed
|
|
NCT00383162
|
2006-11-01 |
A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 1 of 2)
|
Phase 3
|
Completed
|
|
NCT00391846
|
2006-10-01 |
Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone
|
Phase 4
|
Completed
|
|
NCT00384033
|
2006-09-01 |
Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) In The Treatment Of Major Depressive Disorder
|
Phase 3
|
Completed
|
|
NCT00368706
|
2006-09-01 |
A Double-Blind, Paralleled Study Comparing Efficacy/Safety of Solifenacin to Tolterodine in Overactive Bladder Patients
|
Phase 3
|
Completed
|
|
NCT00387881
|
2006-09-01 |
TREXIMET (Formerly Known as TREXIMA) for the Acute Treatment of Probable Migraine (ICHD-II 1.6.1)
|
Phase 3
|
Completed
|
|
NCT00369343
|
2006-09-01 |
Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) Versus Placebo in Peri- and Postmenopausal Women
|
Phase 3
|
Completed
|
|
NCT00385008
|
2006-09-01 |
TREXIMA and RELPAX Gastric Scintigraphy Inside and Outside a Migraine
|
Phase 3
|
Completed
|
|
NCT01050218
|
2006-07-01 |
Study Evaluating the Long-Term Safety of Desvenlafaxine Succinate Sustained-Release (DVS SR) in Subjects With Pain Associated With Diabetic Peripheral Neuropathy
|
Phase 3
|
Terminated
|
|
NCT00356603
|
2006-06-01 |
Study Of Sumatriptan Succinate Injection Kit In Patients With Migraine or Cluster Headache In Japan
|
Phase 3
|
Completed
|
|
NCT00369434
|
2006-06-01 |
Study of the Safety and Efficacy of Desvenlafaxine Succinate for Vasomotor Symptoms in Postmenopausal Women
|
Phase 3
|
Completed
|
|
NCT00333112
|
2006-05-01 |
A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men.
|
Phase 4
|
Completed
|
|
NCT00337558
|
2006-05-01 |
A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder (SOLAR)
|
Phase 4
|
Completed
|
|
NCT01248338
|
2006-03-01 |
Effects of Nebivolol Versus Metoprolol Succinate on Endothelial Function
|
Phase 4
|
Completed
|
|
NCT00273052
|
2006-01-01 |
COREG MR Versus TOPROL-XL On The Lipid Profile Of Normolipidemic Or Mildly Dyslipidemic Patients With Hypertension
|
Phase 3
|
Completed
|
|
NCT00861016
|
2005-10-01 |
Efficacy and Safety of Metoprolol Succinate Prolonged-Release Tablet in Patients With Mild to Moderate Hypertension
|
Phase 4
|
Completed
|
|
NCT00661895
|
2005-08-01 |
Black Education and Treatment of Hypertension (BEAT HTN)
|
Phase 4
|
Completed
|
|
NCT00250653
|
2005-05-01 |
A Fifty-two-week Study to Evaluate the Safety of Saredutant in Adult and Elderly Patients With Depression
|
Phase 3
|
Completed
|
|
NCT00250614
|
2005-04-01 |
An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression
|
Phase 3
|
Completed
|
|
NCT00250601
|
2005-04-01 |
An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression
|
Phase 3
|
Completed
|
|
NCT00250627
|
2004-12-01 |
An Eight-Week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression
|
Phase 3
|
Completed
|
|
NCT00097448
|
2004-12-01 |
Sudden Deafness Treatment Trial
|
Phase 3
|
Completed
|
|
NCT00256113
|
2004-12-01 |
An Eight-Week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression
|
Phase 3
|
Completed
|
|
NCT00650247
|
2004-11-01 |
Food Study of Sumatriptan Succinate Tablets 100 mg to Imitrex® Tablets 100 mg
|
Phase 1
|
Completed
|
|
NCT00648466
|
2004-11-01 |
Fasting Study of Sumatriptan Succinate Tablets 100 mg to Imitrex® Tablets 100 mg
|
Phase 1
|
Completed
|
|
NCT01052428
|
2004-08-01 |
Molecular Mechanisms of Volume Overload-Aim 1(SCCOR in Cardiac Dysfunction and Disease)
|
Phase 2/Phase 3
|
Completed
|
|
NCT00846885
|
2004-08-01 |
Sumatriptan Succinate 100 mg Tablets Under Non-Fasting Conditions
|
Phase 1
|
Completed
|
|
NCT00166400
|
2004-07-01 |
A Randomized Clinical Trial of Metoprolol in Participants With Mitral Regurgitation.
|
Phase 4
|
Completed
|
|
NCT00463541
|
2004-06-01 |
Open-label Study of the Efficacy and Safety of VESIcare® in Patients With Overactive Bladder Symptoms
|
Phase 3
|
Completed
|
|
NCT00057811
|
2004-06-01 |
Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma
|
Phase 2
|
Completed
|
|
NCT00454740
|
2004-06-01 |
Efficacy & Safety Study of VESIcare® (Solifenacin Succinate) in Patients Wishing to Switch From Detrol LA® for Treatment of Overactive Bladder
|
Phase 3
|
Completed
|
|
NCT00801944
|
2004-04-01 |
Solifenacin Succinate 5mg or 10mg Once Daily in the Treatment of Urgency Symptoms
|
Phase 3
|
Completed
|
|
NCT00290602
|
2004-02-01 |
Early Low Dose Steroid Therapy of Acute Respiratory Distress Syndrome
|
Phase 2
|
Completed
|
|
NCT02242812
|
2003-09-01 |
Telmisartan Effectiveness on Left Ventricular Mass Reduction (TELMAR) as Assessed by MRI, in Patients With Mild to Moderate Hypertension
|
Phase 4
|
Terminated
|
|
NCT01309542
|
2003-08-01 |
Long-Term Safety Of DVS-233 SR In Patients With Major Depressive Disorder
|
Phase 3
|
Completed
|
|
NCT00077948
|
2003-07-01 |
Enoximone Plus Extended-Release Metoprolol Succinate in Subjects With Advanced Chronic Heart Failure
|
Phase 3
|
Terminated
|
|
NCT00802373
|
2003-07-01 |
Solifenacin Succinate Versus Tolterodine 4mg Once Daily
|
Phase 3
|
Completed
|
|
NCT00642096
|
2003-06-01 |
Factorial Study of Metoprolol Succinate TOPROL-XL (324A)
|
Phase 3
|
Completed
|
|
NCT00847405
|
2003-03-01 |
Sumatriptan Succinate 100 mg Tablets Under Fasting Conditions
|
Phase 1
|
Completed
|
|
NCT02264002
|
2003-02-01 |
Pharmacodynamic Effects, Safety and Tolerability of Cilobradine, Compared to Metoprolol Succinate and Placebo in Healthy Volunteers
|
Phase 1
|
Completed
|
|
NCT01167946
|
2003-01-01 |
Safety and Efficacy of Oral Mega Pulse Methylprednisolone in Severe Therapy Resistant Alopecia Areata
|
Phase 4
|
Completed
|
|
NCT00648778
|
2003-01-01 |
Fasting Study of Loxapine Succinate Capsules 25 mg and Loxitane® Capsules 25 mg
|
Phase 1
|
Completed
|
|
NCT00255502
|
2002-07-01 |
307B - Safety, Tolerability and Pharmacokinetics Study of TOPROL-XL® in Hypertensive Pediatric Subjects
|
Phase 3
|
Completed
|
|
NCT00255528
|
2002-07-01 |
Dose Ranging, Safety and Tolerability of TOPROL-XL® Extended-Release Tablets in Hypertensive Pediatric Subjects
|
Phase 3
|
Completed
|
|
NCT00147004
|
2002-03-01 |
Corticosteroid Therapy of Septic Shock - Corticus
|
Phase 3
|
Completed
|
|
NCT01798992
|
2000-09-01 |
Effect of Beta-blockers on Structural Remodeling and Gene Expression in the Failing Human Heart
|
Phase 4
|
Completed
|